Saturday, 18 October 2014 • 12:00–16:00 The Shanghai Room, Level 8
The Langham Place Hotel
Mong Kok, Kowloon
We are pleased to invite you to the Metastatic Castration-Resistant Prostate Cancer
(mCRPC) Case Sharing based on the AUA Index Patients.
The last decade has witnessed a remarkable expansion in the number of therapeutic agents for mCRPC. Nevertheless, these advances have made treatment decisions increasingly complex and challenging. This is further compounded by the heterogeneity of the disease and the lack of clinical data informing the optimal treatment sequencing for these agents.
The meeting presents a unique opportunity for both urologists and oncologists to participate in an event dedicated to bridging the gap between best evidence and best practice in mCRPC management. In this case-centric program, expert faculty will highlight effective treatment-sequencing strategies and multidisciplinary approaches to care of patients with mCRPC. Discussions will focus on key clinical data, guideline recommendations and the relative advantages and disadvantages of treatment choices in specific patient types.
In closing, we are confident that you will find this interactive meeting stimulating and worthwhile.